[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_7125 

# __Lack of specific treatments and vaccines for coronavirus infections__

## Articles mentionning the risk

* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)

## Mitigations of this risk

* [Accelerate research and development of specific treatments and vaccines for coronavirus infections](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_9006.md)

## Name of the risk

Increased severity of illness and higher mortality rates due to lack of effective medical interventions

## People affected by this risk

* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Patients with coronavirus infections](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_0.md)
* [Public health authorities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_6001.md)

## Stakeholders who can mitigate this risk

* [Government agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_55.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Biopharmaceutical development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8677.md)
* [Vaccine production technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8678.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

